rs11231531
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001128203.2(PLAAT3):c.16-7836C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0257 in 152,270 control chromosomes in the GnomAD database, including 146 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.026 ( 146 hom., cov: 31)
Consequence
PLAAT3
NM_001128203.2 intron
NM_001128203.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.235
Publications
0 publications found
Genes affected
PLAAT3 (HGNC:17825): (phospholipase A and acyltransferase 3) Enables N-acyltransferase activity; phospholipase A1 activity; and phospholipase A2 activity. Involved in N-acylphosphatidylethanolamine metabolic process. Predicted to be located in several cellular components, including lysosome; nuclear envelope; and peroxisome. Predicted to be active in cytoplasm. Biomarker of seminoma. [provided by Alliance of Genome Resources, Apr 2022]
PLAAT3 Gene-Disease associations (from GenCC):
- lipodystrophy, familial partial, type 9Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0857 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PLAAT3 | NM_001128203.2 | c.16-7836C>T | intron_variant | Intron 2 of 4 | ENST00000415826.3 | NP_001121675.1 | ||
| PLAAT3 | NM_007069.3 | c.16-7836C>T | intron_variant | Intron 1 of 3 | NP_009000.2 | |||
| PLAAT3 | XM_011544741.2 | c.61-7836C>T | intron_variant | Intron 1 of 3 | XP_011543043.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0256 AC: 3893AN: 152152Hom.: 144 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
3893
AN:
152152
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0257 AC: 3916AN: 152270Hom.: 146 Cov.: 31 AF XY: 0.0249 AC XY: 1854AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
3916
AN:
152270
Hom.:
Cov.:
31
AF XY:
AC XY:
1854
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
3658
AN:
41542
American (AMR)
AF:
AC:
190
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5176
South Asian (SAS)
AF:
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27
AN:
68030
Other (OTH)
AF:
AC:
34
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
191
381
572
762
953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.